Research progress in lung transplantation.
10.3760/cma.j.issn.2095-4352.2019.03.024
- Author:
Meng SUN
1
;
Zongmei WEN
Author Information
1. Shanghai Affiliated Hospital of Tongji University, Shanghai 200433, China. Corresponding author: Wen Zongmei, Email: wzm1103@126.com.
- Publication Type:Journal Article
- MeSH:
Biomedical Research/trends*;
Humans;
Lung Transplantation
- From:
Chinese Critical Care Medicine
2019;31(3):375-377
- CountryChina
- Language:Chinese
-
Abstract:
Lung transplantation is the only effective treatment for end-stage lung disease. The problems, including acute rejection, infection, primary graft dysfunction (PGD) and ischemia/reperfusion injury after lung transplantation, as well as surgical techniques and anesthesia management, donor, cardiopulmonary bypass or extracorporeal membrane oxygenation (ECMO), and the main pathogenesis of the receptor, that restrict the development of lung transplantation seriously, and affect the prognosis of patients. Through the description of above major bottlenecks related to lung transplantation and the factors that seriously affect the survival of lung transplant patients and the current response measures, new ideas for the clinical treatment of lung transplantation are presented.
